Scientific work

Dr. Öğr. Üyesi Süreyya Yiğit Kaya

56 publications. The source of the information is stated next to each publication.

Back to profile

  1. Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15020453 PMID 41598391 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Venetoclax-based treatment in adult relapsed/refractory acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center real-world experience

    Journal of Health Sciences and Medicine, 2026

    DOI 10.32322/jhsm.1825832 Open-access full textSource: OpenAlex

  3. Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report

    Turkish Journal of Hematology, 2026

    DOI 10.4274/tjh.galenos.2026.13284 PMID 41914439 Open-access full textSource: OpenAlex

  4. Real-World Experience with Belinostat in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

    Annals of Medical Research, 2026

    DOI 10.5455/annalsmedres.2025.07.193 Open-access full textSource: OpenAlex

  5. Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15135045 PMID 42452507 Open-access full textSource: OpenAlex

  6. A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15145401 PMID 42513315 Open-access full textSource: OpenAlex

  7. Enterovirus Encephalitis Developing After Treatment for Follicular Lymphoma: A Case Report

    SN Comprehensive Clinical Medicine, 2026

    DOI 10.1007/s42399-026-02560-z Source: OpenAlex

  8. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03363-8 PMID 42565930 Open-access full textSource: OpenAlex

  9. Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166365 PMID 42652768 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  10. Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166350 PMID 42652754 Open-access full textSource: OpenAlex

  11. A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient

    Annals of Hematology, 2025

    DOI 10.1007/s00277-024-06118-8 PMID 39847114 1 citation (Europe PMC) Source: OpenAlex

  12. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14207294 PMID 41156164 Open-access full textSource: OpenAlex

  13. Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma

    Turkish Journal of Hematology, 2025

    DOI 10.4274/tjh.galenos.2025.2025.0252 PMID 40859640 Open-access full textSource: OpenAlex

  14. When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06285-2 PMID 40016397 Open-access full textSource: OpenAlex

  15. Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience

    Transplant Immunology, 2025

    DOI 10.1016/j.trim.2025.102286 PMID 40907722 Source: OpenAlex

  16. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14196813 PMID 41095893 Open-access full textSource: OpenAlex

  17. Successful treatment of steroid-refractory gastrointestinal GVHD with ruxolitinib in a patient after autologous stem cell transplantation: a case report

    International Journal of Hematology, 2025

    DOI 10.1007/s12185-025-04073-2 PMID 41004031 Source: OpenAlex

  18. Cutaneous cytomegalovirus infection: a case report

    Skin Health and Disease, 2025

    DOI 10.1093/skinhd/vzaf057 PMID 42222707 Open-access full textSource: OpenAlex

  19. Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14207367 PMID 41156238 Open-access full textSource: OpenAlex

  20. Treatment Outcomes of Elderly Patients with Mantle Cell Lymphoma: A Multi-center Real-World Data

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-025-01979-z PMID 41522546 Source: OpenAlex

  21. The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/j.clml.2025.10.006 PMID 41206323 Source: OpenAlex

  22. MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-694-3_p1 Source: OpenAlex

  23. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience

    Leukemia Research, 2024

    DOI 10.1016/j.leukres.2024.107484 PMID 38520796 3 citations (Europe PMC) Source: OpenAlex

  24. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

    Leukemia Research, 2024

    DOI 10.1016/j.leukres.2024.107495 PMID 38599153 3 citations (Europe PMC) Source: OpenAlex

  25. Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient

    BMC Infectious Diseases, 2024

    DOI 10.1186/s12879-024-10074-z PMID 39448907 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  26. Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients

    Indian Journal of Hematology and Blood Transfusion, 2024

    DOI 10.1007/s12288-024-01841-8 PMID 39917490 Open-access full textSource: OpenAlex

  27. Urinary Neutrophil Gelatinase-Associated Lipocalin Levels as an Indicator of Early Kidney Injury in Patients with Type 2 Diabetes Mellitus

    Lokman Hekim Health Sciences, 2024

    DOI 10.14744/lhhs.2023.5001 Source: OpenAlex

  28. Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case

    Frontiers in Immunology, 2023

    DOI 10.3389/fimmu.2023.1276295 PMID 37901215 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  29. Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient

    Annals of Hematology, 2023

    DOI 10.1007/s00277-023-05231-4 PMID 37099080 3 citations (Europe PMC) Source: OpenAlex

  30. Acute Myeloid Leukemia in Elderly, Unfit Patients: Analysis of Turkish AML Prospective Registry Database, on Behalf of Acute Leukemia Working Group of Turkish Society of Hematology

    Blood, 2023

    DOI 10.1182/blood-2023-189714 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  31. Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis

    Eurasian Journal of Medicine and Oncology, 2023

    DOI 10.14744/ejmo.2023.64688 Open-access full textSource: OpenAlex

  32. Recurrent Herpes Infection in Two Cases with Chronic Myeloid Leukemia Using Dasatinib

    Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 2023

    DOI 10.47572/muskutd.1015154 Source: OpenAlex

  33. Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder

    Leukemia Research Reports, 2023

    DOI 10.1016/j.lrr.2023.100369 PMID 37213444 Open-access full textSource: OpenAlex

  34. Primary Thyroid Lymphoma: A Nationwide Retrospective Cohort Analysis of Survival and Determinant Factors

    Research Square, 2023

    DOI 10.21203/rs.3.rs-3635621/v1 Open-access full textSource: OpenAlex

  35. Prospective Real-World Outcomes of Acute Myeloid Leukemia

    Blood, 2023

    DOI 10.1182/blood-2023-182800 Open-access full textSource: OpenAlex

  36. Retrospective Analysis of Turkish AML Registry Database, on Behalf of AML Working Group of Turkish Society of Hematology

    Blood, 2022

    DOI 10.1182/blood-2022-167639 Source: OpenAlex

  37. Brentuximab vedotin related bilateral Purtscher-like retinopathy unresponsive to pulse steroid therapy and intravitreal aflibercept injection

    Europe PMC (PubMed Central), 2017

    DOI 10.3205/oc000080 PMID 29326861 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  38. Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

    Kocaeli Üniversitesi - AVESİS, 2017

    Source: OpenAlex

  39. Urinary kidney injury molecule-1 levels as a marker of early kidney injury in hypertensive patients.

    PubMed, 2016

    PMID 25923545 7 citations (Europe PMC) Source: OpenAlex

  40. Akut Myeloid Lösemi Hastalarımızın Retrospektif Değerlendirilmesi

    DergiPark (Istanbul University), 1899

    Source: OpenAlex

  41. ULUSLARARASI VE ULUSAL YAYINLAR:

    Source: medipol.com.tr profile page

  42.  F. Özdemirkıran, Serife Solmaz Medeni, Füsun Özdemirkıran, K. B. Payzın, Kadriye Bahriye Payzın, Ö. G. Sevindik, C. Acar, Ömür Gökmen Sevindik, Celal Acar, D. Türkyılmaz, Doğuş Türkyılmaz, S. Yiğit Kaya, İ. Alacacıoğlu, Süreyya Yiğit Kaya, Ö. Pişkin, İnci Alacacıoğlu, F. Demirkan, Özden Pişkin, H. G. Özsan, Fatih Demirkan, Hayri Güner Özsan, M. A. Özcan, Mehmet Ali Özcan. Paroksismal Nokturnal Hemoglobinürili Olguların Değerlendirilmesi: İki Merkezin Deneyimi. DEU Tıp Derg. 01 Aralık 2014;28(3):139-43. doi:10.18614/deutfd.40684

    Source: medipol.com.tr profile page

  43.  Sevindik, Ö. G., Acar, C., Türkyılmaz, D., Kaya, S. Y., Alacacıoğlu, İ., Pişkin, Ö., Özcan, M. A., Demirkan, F., & Özsan, H. G. (2015). Retrospectıve Evaluatıon Of Patıents Treated Wıth Double Fıltratıon Plasmapheresıs. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, 19(4), 181-185. https://izlik.org/JA23BZ27JW

    Source: medipol.com.tr profile page

  44.  Kaya, Sureyya Yigit, et al. "Belinostat in relapsed/refractory peripheral T-cell lymphoma: A real-world multicenter experience." Annals of Medical Research 33.4 (2026): 178-184. https://www.annalsmedres.org/index.php/aomr/article/view/4910

    Source: medipol.com.tr profile page

  45. KİTAPLAR VE KİTAP ÇEVİRİLERİ:

    Source: medipol.com.tr profile page

  46.  KAYA, Süreyya YİĞİT, and Güner Hayri ÖZSAN. "AL Amiloidoz." Turkiye Klinikleri Hematology-Special Topics 11.2 (2018): 140-146.

    Source: medipol.com.tr profile page

  47.  Kaya, S. Y. (2025). Yaşlı hastada akut lenfoblastik lösemi yönetimi.

    Source: medipol.com.tr profile page

  48. N. A. Soyer, S. Savaş, & F. Şahin (Ed.), Yaşlı hastada malign hematolojik hastalıklara yaklaşım (s.23-29). US Akademi.

    Source: medipol.com.tr profile page

  49.  Kaya, S. Y. (2023). Vitamin B12 ve folik asit eksikliği anemisi.

    Source: medipol.com.tr profile page

  50. D. Çekiç & K. İşsever (Ed.), Genel dahiliyede güncel konular (s. 15-24). Livre de Lyon.

    Source: medipol.com.tr profile page